Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Bausch & Lomb Incorporated

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1992-10-08

Employees: -

Market Cap: -

Website

Clinical Trials

Study to Evaluate the Safety and Effectiveness of the enVista® Beyond (EY) EDF Intraocular Lens in Subjects Undergoing Cataract Extraction

Not Applicable

Recruiting

Conditions: Cataract

First Posted Date: 2024-03-27

Last Posted Date: 2025-07-02

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 224

Registration Number: NCT06333015

Locations: 🇺🇸
Site 115, Sugar Land, Texas, United States
🇺🇸
Site 108, Northridge, California, United States
🇺🇸
Site 107, Bloomington, Minnesota, United States

and more 9 locations

A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease

Phase 4

Completed

Conditions: Dry Eye

Interventions: Drug: Miebo

First Posted Date: 2024-03-13

Last Posted Date: 2024-06-21

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 99

Registration Number: NCT06309953

Locations: 🇺🇸
Site 205, Petaluma, California, United States
🇺🇸
Site 203, Pittsburg, Kansas, United States
🇺🇸
Site 204, Stillwater, Minnesota, United States

and more 2 locations

A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children

Not Applicable

Recruiting

Conditions: Myopia

First Posted Date: 2024-03-12

Last Posted Date: 2025-06-15

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 418

Registration Number: NCT06305663

Locations: 🇨🇳
Site 105, Beijing, Beijing, China
🇨🇳
Site 107, Dongcheng, Beijing, China
🇨🇳
Site 109, Xiamen, Fujian, China

and more 8 locations

Kalifilcon A Toric Compared to Commercially Available Lenses

Not Applicable

Completed

Conditions: Astigmatism

First Posted Date: 2023-10-25

Last Posted Date: 2024-12-10

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 30

Registration Number: NCT06098937

Locations: 🇺🇸
Bausch & Lomb, Incorporated, Rochester, New York, United States

Orientation Characteristics of Daily Disposable Toric Contact Lenses

Not Applicable

Completed

Conditions: Astigmatism

First Posted Date: 2023-10-06

Last Posted Date: 2025-07-01

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 30

Registration Number: NCT06069609

Locations: 🇺🇸
Bausch & Lomb, Incorporated, Rochester, New York, United States

IC-8 Apthera IOL New Enrollment Post Approval Study

Recruiting

Conditions: Cataract
Posterior Capsule Opacification
Presbyopia

First Posted Date: 2023-09-29

Last Posted Date: 2025-01-17

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 435

Registration Number: NCT06060041

Locations: 🇺🇸
Trinity Research Group, LLC, Dothan, Alabama, United States
🇺🇸
Feinerman Vision Center, Newport Beach, California, United States
🇺🇸
Argus Research Center, Cape Coral, Florida, United States

and more 9 locations

1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact Lenses

Not Applicable

Completed

Conditions: Refractive Ametropia

First Posted Date: 2023-09-26

Last Posted Date: 2024-01-05

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 26

Registration Number: NCT06053736

Locations: 🇺🇸
Bausch & Lomb, Incorporated, Rochester, New York, United States

Study of Safety and Effectiveness of the Boston Orthokeratology Shaping Lens in the Arise Orthokeratology Lens

Not Applicable

Completed

Conditions: Astigmatism

First Posted Date: 2023-08-09

Last Posted Date: 2024-08-26

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 90

Registration Number: NCT05984290

Locations: 🇺🇸
Levenson Eye Associates, Jacksonville, Florida, United States
🇺🇸
Birmingham Vision Care P.C., Bloomfield, Michigan, United States
🇺🇸
Cornea and Contact Lens Institute of Minnesota, Edina, Minnesota, United States

and more 3 locations

Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution

Completed

Conditions: Allergic Conjunctivitis

First Posted Date: 2023-04-18

Last Posted Date: 2024-06-12

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 511

Registration Number: NCT05815758

Locations: 🇺🇸
104- Arizona Eye Center, Chandler, Arizona, United States
🇺🇸
103- Seidenberg Protzko Eye Associates, Havre De Grace, Maryland, United States
🇺🇸
101 - Andover Eye Associates, Andover, Massachusetts, United States

and more 4 locations

Evaluation of Visual Acuity of the Envista One-piece Acrylic Toric IOL MX60ET

Completed

Conditions: Astigmatism

First Posted Date: 2023-02-22

Last Posted Date: 2023-02-22

Lead Sponsor: Bausch & Lomb Incorporated

Target Recruit Count: 100

Registration Number: NCT05739656

Locations: 🇺🇸
Jeffrey Whitman, MD, Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy